Dexcom Announces Upcoming Conference Presentation

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ: DXCM) today announced that management will present an update on the company at the 46th Annual Raymond James Institutional Investors Conference on Tuesday, March 4th.

The live presentation is scheduled to begin at approximately 10:25 AM EST and will be concurrently webcast.

Links to the webcast will be available on the Dexcom Investor Relations website at investors.dexcom.com and will be archived there for future reference.

About DexCom, Inc.

Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.

Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com.

Category: IR

View source version on businesswire.com: https://www.businesswire.com/news/home/20250227437291/en/

DexCom, Inc.
Sean Christensen
Vice President – Finance and Investor Relations
[email protected]
(858) 200-0200

Source: DexCom, Inc.

You May Also Be Interested In

• Arkema Obtains Validation From SBTi Services for Its New Climate Targets for 2035 and Net Zero by 2050
• Ahead of Black Friday, One in Five U.S. and UK Consumers Have Stopped Using a Retail Brand Over Data Privacy Concerns, Usercentrics Research Finds
• GLORIA Study Team Receives the 2026 German University Medicine Prize for Its Glioblastoma Research with CXCL12 Inhibitor NOX-A12